The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 340:735 March 4, 1999 Number 9
NextNext

Warfarin-Induced Skin Necrosis in a Patient with a Mutation of the Prothrombin Gene

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: Skin necrosis is a rare complication of warfarin therapy.1 The necrotic lesions usually appear in a distinct pattern, with a predilection for fatty tissues such as the breasts, buttocks, and thighs, three to six days after the initiation of warfarin therapy. The pathophysiology underlying warfarin-induced skin necrosis is not entirely understood. Hypercoagulability has been found in patients with necrosis and in some cases correlates with hereditary conditions such as deficiencies of protein C, protein S, and antithrombin III.2 We describe a case of warfarin-induced skin necrosis in a patient with a G20210A mutation of the prothrombin gene . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.